PARylated PDHE1α generates acetyl-CoA for local chromatin acetylation and DNA damage repair.


Journal

Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 18 08 2022
accepted: 21 08 2023
medline: 15 11 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: ppublish

Résumé

Chromatin relaxation is a prerequisite for the DNA repair machinery to access double-strand breaks (DSBs). Local histones around the DSBs then undergo prompt changes in acetylation status, but how the large demands of acetyl-CoA are met is unclear. Here, we report that pyruvate dehydrogenase 1α (PDHE1α) catalyzes pyruvate metabolism to rapidly provide acetyl-CoA in response to DNA damage. We show that PDHE1α is quickly recruited to chromatin in a polyADP-ribosylation-dependent manner, which drives acetyl-CoA generation to support local chromatin acetylation around DSBs. This process increases the formation of relaxed chromatin to facilitate repair-factor loading, genome stability and cancer cell resistance to DNA-damaging treatments in vitro and in vivo. Indeed, we demonstrate that blocking polyADP-ribosylation-based PDHE1α chromatin recruitment attenuates chromatin relaxation and DSB repair efficiency, resulting in genome instability and restored radiosensitivity. These findings support a mechanism in which chromatin-associated PDHE1α locally generates acetyl-CoA to remodel the chromatin environment adjacent to DSBs and promote their repair.

Identifiants

pubmed: 37735618
doi: 10.1038/s41594-023-01107-3
pii: 10.1038/s41594-023-01107-3
doi:

Substances chimiques

Chromatin 0
Acetyl Coenzyme A 72-89-9
Pyruvates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1719-1734

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071–1078 (2009).
pubmed: 19847258 pmcid: 2906700
Ceccaldi, R., Rondinelli, B. & D’Andrea, A. D. Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 26, 52–64 (2016).
pubmed: 26437586
Ciccia, A. & Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179–204 (2010).
pubmed: 20965415 pmcid: 2988877
Smerdon, M. J. DNA repair and the role of chromatin structure. Curr. Opin. Cell Biol. 3, 422–428 (1991).
pubmed: 1892653
Soria, G., Polo, S. E. & Almouzni, G. Prime, repair, restore: the active role of chromatin in the DNA damage response. Mol. Cell 46, 722–734 (2012).
pubmed: 22749398
Price, B. D. & D’Andrea, A. D. Chromatin remodeling at DNA double-strand breaks. Cell 152, 1344–1354 (2013).
pubmed: 23498941 pmcid: 3670600
Kim, J. J., Lee, S. Y. & Miller, K. M. Preserving genome integrity and function: the DNA damage response and histone modifications. Crit. Rev. Biochem. Mol. Biol. 54, 208–241 (2019).
pubmed: 31164001 pmcid: 6715524
Zhang, J. et al. Histone lysine modifying enzymes and their critical roles in DNA double-strand break repair. DNA Repair (Amst.) 107, 103206 (2021).
pubmed: 34411909
Downs, J. A. et al. Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol. Cell 16, 979–990 (2004).
pubmed: 15610740
Murr, R. et al. Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat. Cell Biol. 8, 91–99 (2006).
pubmed: 16341205
Sivanand, S. et al. Nuclear acetyl-CoA production by ACLY promotes homologous recombination. Mol. Cell 67, 252–265 e256 (2017).
pubmed: 28689661 pmcid: 5580398
Shogren-Knaak, M. et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311, 844–847 (2006).
pubmed: 16469925
Xu, Y. et al. Histone H2A.Z controls a critical chromatin remodeling step required for DNA double-strand break repair. Mol. Cell 48, 723–733 (2012).
pubmed: 23122415 pmcid: 3525728
Xu, Y. et al. The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J. Cell Biol. 191, 31–43 (2010).
pubmed: 20876283 pmcid: 2953432
Etchegaray, J. P. & Mostoslavsky, R. Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes. Mol. Cell 62, 695–711 (2016).
pubmed: 27259202 pmcid: 4893201
Kinnaird, A., Zhao, S., Wellen, K. E. & Michelakis, E. D. Metabolic control of epigenetics in cancer. Nat. Rev. Cancer 16, 694–707 (2016).
pubmed: 27634449
Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F. & Kroemer, G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21, 805–821 (2015).
pubmed: 26039447
Menzies, K. J., Zhang, H., Katsyuba, E. & Auwerx, J. Protein acetylation in metabolism – metabolites and cofactors. Nat. Rev. Endocrinol. 12, 43–60 (2016).
pubmed: 26503676
Sivanand, S., Viney, I. & Wellen, K. E. Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation. Trends Biochem. Sci. 43, 61–74 (2018).
pubmed: 29174173
Tsuchiya, Y., Pham, U. & Gout, I. Methods for measuring CoA and CoA derivatives in biological samples. Biochem. Soc. Trans. 42, 1107–1111 (2014).
pubmed: 25110010
Yi, C. H. et al. Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival. Cell 146, 607–620 (2011).
pubmed: 21854985 pmcid: 3182480
Kim, J. W. & Dang, C. V. Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 30, 142–150 (2005).
pubmed: 15752986
Siebert, G. & Humphrey, G. B. Enzymology of the nucleus. Adv. Enzymol. Relat. Areas Mol. Biol. 27, 239–288 (1965).
pubmed: 4303032
Gao, X. L., Wang, H. Z., Yang, J. J., Liu, X. W. & Liu, Z. R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 45, 598–609 (2012).
pubmed: 22306293 pmcid: 3299833
Monaghan, R. M. & Whitmarsh, A. J. Mitochondrial proteins moonlighting in the nucleus. Trends Biochem. Sci. 40, 728–735 (2015).
pubmed: 26520802
Li, X. et al. Nucleus-translocated ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy. Mol. Cell 66, 684–697.e9 (2017).
pubmed: 28552616 pmcid: 5521213
Chen, W. et al. The SESAME complex regulates cell senescence through the generation of acetyl-CoA. Nat. Metab. https://doi.org/10.1038/s42255-021-00412-9 (2021).
doi: 10.1038/s42255-021-00412-9 pubmed: 34663976 pmcid: 8422857
Sutendra, G. et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 158, 84–97 (2014).
pubmed: 24995980
Chen, J. et al. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat. Genet. 50, 219–228 (2018).
pubmed: 29335542 pmcid: 5810912
Zhang, J. et al. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma. Oncogene 38, 4669–4684 (2019).
pubmed: 30745576 pmcid: 6756087
Nagaraj, R. et al. Nuclear localization of mitochondrial TCA cycle enzymes as a critical step in mammalian zygotic genome activation. Cell 168, 210–223 (2017).
pubmed: 28086092 pmcid: 5321559
Liu, C. & Yu, X. ADP-ribosyltransferases and poly ADP-ribosylation. Curr. Protein Pept. Sci. 16, 491–501 (2015).
pubmed: 25938242 pmcid: 4725697
Wei, H. & Yu, X. Functions of PARylation in DNA damage repair pathways. Genomics Proteomics Bioinformatics 14, 131–139 (2016).
pubmed: 27240471 pmcid: 4936651
Messner, S. & Hottiger, M. O. Histone ADP-ribosylation in DNA repair, replication and transcription. Trends Cell Biol. 21, 534–542 (2011).
pubmed: 21741840
Kumbhar, R. et al. Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions. J. Cell Biol. 220, e202006149 (2021).
pubmed: 34003252 pmcid: 8135068
Chen, Q. et al. ADP-ribosylation of histone variant H2AX promotes base excision repair. EMBO J. 40, e104542 (2021).
pubmed: 33264433
Li, Z. M. et al. Destabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair. Cell Res. 28, 756–770 (2018).
pubmed: 29844578 pmcid: 6028381
Leidecker, O. et al. Serine is a new target residue for endogenous ADP-ribosylation on histones. Nat. Chem. Biol. 12, 998–1000 (2016).
pubmed: 27723750 pmcid: 5113755
Krishnakumar, R. & Kraus, W. L. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39, 8–24 (2010).
pubmed: 20603072 pmcid: 2923840
Robson, M. et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N. Engl. J. Med. 377, 523–533 (2017).
pubmed: 28578601
Ledermann, J. et al. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N. Engl. J. Med. 366, 1382–1392 (2012).
pubmed: 22452356
Clouaire, T. et al. Comprehensive mapping of histone modifications at DNA double-strand breaks deciphers repair pathway chromatin signatures. Mol. Cell 72, 250–262 (2018).
pubmed: 30270107 pmcid: 6202423
Iacovoni, J. S. et al. High-resolution profiling of γH2AX around DNA double strand breaks in the mammalian genome. EMBO J. 29, 1446–1457 (2010).
pubmed: 20360682 pmcid: 2868577
Trefely, S. et al. Quantitative subcellular acyl-CoA analysis reveals distinct nuclear metabolism and isoleucine-dependent histone propionylation. Mol. Cell 82, 447–462.e6 (2022).
pubmed: 34856123
Behal, R. H., Buxton, D. B., Robertson, J. G. & Olson, M. S. Regulation of the pyruvate dehydrogenase multienzyme complex. Annu. Rev. Nutr. 13, 497–520 (1993).
pubmed: 8369156
Arce-Molina, R. et al. A highly responsive pyruvate sensor reveals pathway-regulatory role of the mitochondrial pyruvate carrier MPC. eLife 9, e53917 (2020).
pubmed: 32142409 pmcid: 7077990
Hansen, L. L., Brown, G. K., Kirby, D. M. & Dahl, H. H. Characterization of the mutations in three patients with pyruvate dehydrogenase E1α deficiency. J. Inherit. Metab. Dis. 14, 140–151 (1991).
pubmed: 1909401
Parrini, E. et al. Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum. Mutat. 38, 216–225 (2017).
pubmed: 27864847
Lissens, W. et al. Mutation analysis of the pyruvate dehydrogenase E
pubmed: 8664900
Gong, F., Chiu, L. Y. & Miller, K. M. Acetylation reader proteins: linking acetylation signaling to genome maintenance and cancer. PLoS Genet. 12, e1006272 (2016).
pubmed: 27631103 pmcid: 5025232
Li, X., Qian, X. & Lu, Z. Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy. Autophagy 13, 1790–1791 (2017).
pubmed: 28820290 pmcid: 5640193
Carrer, A. et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Discov. 9, 416–435 (2019).
pubmed: 30626590 pmcid: 6643997
Lee, J. V. et al. Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca
pubmed: 29674394 pmcid: 5959234
Liu, X. et al. Acetate production from glucose and coupling to mitochondrial metabolism in mammals. Cell 175, 502–513.e13 (2018).
pubmed: 30245009 pmcid: 6173642
Sulkowski, P. L. et al. Oncometabolites suppress DNA repair by disrupting local chromatin signalling. Nature 582, 586–591 (2020).
pubmed: 32494005 pmcid: 7319896
Chen, L. L. & Xiong, Y. Tumour metabolites hinder DNA repair. Nature 582, 492–494 (2020).
pubmed: 32572248 pmcid: 7576997
Gibson, B. A. & Kraus, W. L. Small molecules, big effects: a role for chromatin-localized metabolite biosynthesis in gene regulation. Mol. Cell 41, 497–499 (2011).
pubmed: 21362545 pmcid: 3133593
Trefely, S., Lovell, C. D., Snyder, N. W. & Wellen, K. E. Compartmentalised acyl-CoA metabolism and roles in chromatin regulation. Mol. Metab. https://doi.org/10.1016/j.molmet.2020.01.005 (2020).
Jiang, Y. H. et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 17, 1158–1168 (2015).
pubmed: 26237645 pmcid: 4800990
Gustafsson, N. M. S. et al. Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination. Nat. Commun. 9, 3872 (2018).
pubmed: 30250201 pmcid: 6155239
Tallis, M., Morra, R., Barkauskaite, E. & Ahel, I. Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response. Chromosoma 123, 79–90 (2014).
pubmed: 24162931
Guo, Y., Fan, B. & Li, M. PARP molecular functions and applications of PARP inhibitors in cancer treatment. Genome Instab. Dis. 4, 137–153 (2023).
Gibson, B. A. et al. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Science 353, 45–50 (2016).
pmcid: 5540732
Li, N. et al. PARP inhibition suppresses growth of EGFR-mutant cancers by targeting nuclear PKM2. Cell Rep. 15, 843–856 (2016).
pubmed: 27149849 pmcid: 5063668
Gupte, R., Liu, Z. Y. & Kraus, W. L. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 31, 101–126 (2017).
pubmed: 28202539 pmcid: 5322727
Ahel, I. et al. Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature 451, 81–85 (2008).
pubmed: 18172500
Zhang, L. & Li, D. Q. MORC2 regulates DNA damage response through a PARP1-dependent pathway. Nucleic Acids Res. 47, 8502–8520 (2019).
pmcid: 6895267
Hassa, P. O. et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription. J. Biol. Chem. 280, 40450–40464 (2005).
pubmed: 16204234
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
pubmed: 21376230
Vernieri, C. et al. Targeting cancer metabolism: dietary and pharmacologic interventions. Cancer Discov. 6, 1315–1333 (2016).
pubmed: 27872127 pmcid: 5140697
Sun, L., Zhang, H. & Gao, P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell https://doi.org/10.1007/s13238-021-00846-7 (2021).
doi: 10.1007/s13238-021-00846-7 pubmed: 34813054 pmcid: 8934370
Vander Heiden, M. G. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10, 671–684 (2011).
Martinez-Outschoorn, U. E., Peiris-Pages, M., Pestell, R. G., Sotgia, F. & Lisanti, M. P. Cancer metabolism: a therapeutic perspective. Nat. Rev. Clin. Oncol. 14, 113 (2017).
pubmed: 28094266
Cai, Z. et al. Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis. Mol. Cell 80, 263–278.e7 (2020).
pubmed: 33022274 pmcid: 7534735
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
Stacpoole, P. W. Therapeutic targeting of the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis in cancer. J. Natl Cancer Inst. https://doi.org/10.1093/jnci/djx071 (2017).
Aymard, F. et al. Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks. Nat. Struct. Mol. Biol. 21, 366–U172 (2014).
pubmed: 24658350 pmcid: 4300393
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
pubmed: 25075903 pmcid: 4486245
Hou, T. et al. SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair. Nucleic Acids Res. 48, 2982–3000 (2020).
pubmed: 31970415 pmcid: 7102973
Liao, W., McNutt, M. A. & Zhu, W. G. The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods 48, 46–53 (2009).
pubmed: 19269328
Hou, T. et al. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation. Mol. Cell 82, 4099–4115.e9 (2022).
pubmed: 36208627
Zhao, Y., Shen, Y., Wen, Y. & Campbell, R. E. High-performance intensiometric direct- and inverse-response genetically encoded biosensors for citrate. ACS Cent. Sci. 6, 1441–1450 (2020).
pubmed: 32875085 pmcid: 7453566
Nelson, J. D., Denisenko, O. & Bomsztyk, K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1, 179–185 (2006).
pubmed: 17406230
Dejardin, J. & Kingston, R. E. Purification of proteins associated with specific genomic loci. Cell 136, 175–186 (2009).
pubmed: 19135898 pmcid: 3395431

Auteurs

Jun Zhang (J)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Feng Chen (F)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Yuan Tian (Y)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Wenchao Xu (W)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Qian Zhu (Q)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Zhenhai Li (Z)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Lingyu Qiu (L)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Xiaopeng Lu (X)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Bin Peng (B)

Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Cell Biology and Medical Genetics, Shenzhen University Medical School, Shenzhen, China.

Xiangyu Liu (X)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.

Haiyun Gan (H)

Shenzhen Key Laboratory of Synthetic Genomics, Guangdong Provincial Key Laboratory of Synthetic Genomics, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Baohua Liu (B)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China.
Shenzhen Key Laboratory for Systemic Aging and Intervention, National Engineering Research Center for Biotechnology (Shenzhen), Shenzhen University Medical School, Shenzhen, China.

Xingzhi Xu (X)

Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Cell Biology and Medical Genetics, Shenzhen University Medical School, Shenzhen, China.

Wei-Guo Zhu (WG)

International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen, China. zhuweiguo@szu.edu.cn.

Articles similaires

DNA Glycosylases Nucleosomes Humans 8-Hydroxy-2'-Deoxyguanosine DNA Repair
Humans Induced Pluripotent Stem Cells Schizophrenia Neural Stem Cells DNA Damage

Novel

Febe Ferro, C Roland Wolf, Christopher Henstridge et al.
1.00
Amyotrophic Lateral Sclerosis Animals Mice DNA-Binding Proteins Disease Models, Animal
Humans Ku Autoantigen Ataxia Telangiectasia Mutated Proteins Male DNA-Activated Protein Kinase

Classifications MeSH